MindWalk (NASDAQ:HYFT) Trading Down 2.1% – Here’s Why

MindWalk Holdings Corp. (NASDAQ:HYFT)’s stock price fell 2.1% during mid-day trading on Friday . The stock traded as low as $1.39 and last traded at $1.43. Approximately 140,227 shares changed hands during trading, a decline of 45% from the average daily volume of 256,183 shares. The stock had previously closed at $1.46.

Analyst Ratings Changes

HYFT has been the subject of several recent analyst reports. HC Wainwright reaffirmed a “buy” rating and issued a $5.00 target price on shares of MindWalk in a research report on Tuesday, May 19th. JonesTrading assumed coverage on MindWalk in a research report on Thursday, April 16th. They set a “buy” rating and a $5.00 price target on the stock. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $5.00.

MindWalk Price Performance

The company has a debt-to-equity ratio of 0.21, a current ratio of 3.74 and a quick ratio of 3.64. The company has a market cap of $66.01 million, a price-to-earnings ratio of -7.15 and a beta of 0.83. The company has a fifty day moving average of $1.53.

Institutional Investors Weigh In On MindWalk

A number of institutional investors have recently modified their holdings of HYFT. Virtu Financial LLC purchased a new position in shares of MindWalk during the 4th quarter valued at $51,000. Bridgeway Capital Management LLC purchased a new stake in shares of MindWalk during the fourth quarter worth $91,000. Bank of Montreal Can boosted its position in MindWalk by 81.0% during the fourth quarter. Bank of Montreal Can now owns 54,750 shares of the company’s stock valued at $100,000 after purchasing an additional 24,500 shares during the last quarter. XTX Topco Ltd boosted its position in MindWalk by 118.6% during the fourth quarter. XTX Topco Ltd now owns 81,721 shares of the company’s stock valued at $149,000 after purchasing an additional 44,331 shares during the last quarter. Finally, Jane Street Group LLC grew its stake in MindWalk by 147.3% in the fourth quarter. Jane Street Group LLC now owns 161,202 shares of the company’s stock valued at $293,000 after purchasing an additional 96,018 shares in the last quarter. Institutional investors and hedge funds own 6.70% of the company’s stock.

MindWalk Company Profile

ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and related services in the United States, Canada, Europe, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multi-species antibody discovery; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing; antibody characterization on label-free biosensors and antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production with multiplexed, high-throughput screening, and clone-picking; and cryopreservation.